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S U M M A R Y
Factors related to bacterial virulence and/or to the host have been implicated in the pathogenesis of
recurrent urinary tract infections (rUTI), but in most cases the cause is unknown. Mannose binding lectin
(MBL) is an acute phase glycoprotein that exerts immunological functions by binding to the surface of a
variety of pathogens. Some human gene variants reduce MBL activity thereby predisposing the host to
bacterial and viral infections. The aim of this study was to investigate MBL2 gene variants in relation to
rUTI risk. Six MBL gene variants and seven haplotypes were analyzed by PCR and direct sequencing in
rUTI patients (n = 83) and in healthy subjects from southern Italy (n = 642). The frequencies of the L allele
(550) and the HYPA haplotype were higher in controls than in patients stratiﬁed according to sex (p <
0.05). Our data indicate that the HYPA haplotype in the MBL2 gene could be associated with a minor risk
of developing rUTI in males.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Recurrent urinary tract infections (rUTI) are symptomatic
episodes that follow the resolution of earlier episodes.1 rUTI due
to chronic bacterial infections is less frequent in men than in
women.1,2 Several factors related to bacteria or to the host,
including genetic susceptibility,3 have been implicated in rUTI
pathogenesis. Mannose binding lectin (MBL), which is an acute
phase serum glycoprotein that exerts immunological effects,4,5
may play a role in the pathogenesis of rUTI.
Common MBL nucleotide alterations are essentially located in
the promoter region and/or in the coding region of the MBL2 gene.     
* Corresponding author. Tel.: +39 081 3737819; fax: +39 081 3737808.
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http://dx.doi.org/10.1016/j.ijid.2013.10.019They reduce the synthesis and/or the function of the gene thereby
resulting in increased susceptibility to bacterial infections.4,5 MBL
activity has been associated with various diseases.6,7 MBL2 is a
modiﬁer gene for the cystic ﬁbrosis phenotype, and alterations in
this gene have been associated with gastric cancer in patients with
Helicobacter pylori infection.6,7 To date, no data have been reported
regarding the relationships between MBL2 gene variants and
susceptibility to rUTI.
To investigate whether MBL variants are involved in rUTI
pathogenesis, we studied the structural and promoter alleles,
genotypes, and haplotypes of the MBL2 gene in a cohort of rUTI
patients compared to a cohort of healthy subjects living in
southern Italy.
2. Materials and methods
Forty-six unrelated men with rUTI (25–80 years, mean 59.9
years) and 37 women with rUTI (21–49 years, mean 39 years)8
were enrolled in the study. None had a history of surgery, and noneciety for Infectious Diseases. Open access under CC BY-NC-SA license.
Table 1
Genotype frequencies in patients and controls
Position and allelic genotype Control F
(n = 308),
n (%)
Control M
(n = 334),
n (%)
Case F
(n = 37),
n (%)
Case M
(n = 46),
n (%)
ap-Value bp-Value OR (95% CI) OR (95% CI)
Promoter Position 550 H/H 103 (33.4) 111 (33.2) 15 (40.5) 23 (50.0) 0.69 0.02 0.90 (0.55–1.48) 0.55 (0.33–0.90)
H/L 162 (52.6) 178 (53.3) 16 (43.2) 21 (45.7)
L/L 43 (14.0) 45 (13.5) 6 (16.2) 2 (4.3)
Position 221 Y/Y 187 (60.7) 200 (59.9) 23 (62.2) 27 (58.7) 0.88 0.99 0.95 (0.53–1.71) 1.00 (0.59–1.68)
Y/X 104 (33.8) 116 (34.7) 12 (32.4) 17 (37.0)
XX 17 (5.5) 18 (5.4) 2 (5.4) 2 (4.3)
Position +4 P/P 199 (64.6) 217 (65.0) 19 (51.4) 25 (54.3) 0.15 0.08 1.50 (0.86–2.59) 1.55 (0.94–2.56)
P/Q 96 (31.2) 105 (31.4) 16 (43.2) 17 (37.0)
Q/Q 13 (4.2) 12 (3.6) 2 (5.4) 4 (8.7)
Exon 1
Codon 52 Position +223 A/A 275 (89.3) 305 (91.3) 34 (91.9) 41 (89.1) 0.79 0.58 0.74 (0.22–2.49) 1.35 (0.50–3.61)
A/D 33 (10.7) 27 (8.1) 3 (8.1) 5 (10.9)
D/D 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Codon 54 Position +230 A/A 238 (77.3) 257 (76.9) 31 (83.8) 29 (63.0) 0.24 0.08 0.60 (0.25–1.42) 1.64 (0.93–2.89)
A/B 61 (19.8) 68 (20.4) 6 (16.2) 16 (34.8)
B/B 9 (2.9) 9 (2.7) 0 (0.0) 1 (2.2)
Codon 57 Position +239 A/A 300 (97.4) 322 (96.4) 35 (94.6) 45 (97.8) 0.64 0.6 2.11 (0.44–10.13) 0.60 (0.07–4.67)
A/C 8 (2.6) 12 (3.6) 2 (5.4) 1 (2.2)
C/C 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
F, females; M, males.
a p-Values from allele comparison of case F vs. control F.
b p-Values from allele comparison of case M vs. control M.
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a positive Meares test.9 The etiological agents identiﬁed in the 46
male patients were Escherichia coli (69.5%), Proteus mirabilis (13%),
Klebsiella pneumoniae (8.6%), and Streptococcus faecalis (4.3%). Two
patients (4.3%) had Gram-positive Corynebacterium. The inclusion
criteria for women were: not pregnant or pre-menopausal, no
functional or structural abnormalities, and the occurrence of two
rUTIs in 6 months or three episodes per year. The bacteria
identiﬁed in the 37 women were E. coli (88%), S. faecalis (5%), P.
mirabilis (2.5%), K. pneumoniae (2.5%), and Pseudomonas spp (2%).
Laboratory analyses of the entire cohort of patients screened
excluded leukocyte, immunoglobulin, and complement altera-
tions. The control group comprised 642 unrelated healthy adults
from southern Italy (334 men and 308 women).
All individuals enrolled in the study provided written informed
consent. The study was approved and conducted in accordance
with the ethical principles stated in the most recent version of the
Declaration of Helsinki.
Genomic DNA was extracted from each blood sample using
commercial procedures. DNA was analyzed for the MBL2 gene (the
promoter, 50 untranslated region (UTR), and exon 1) by PCR
followed by direct sequencing. MBL2 mutations in exon 1 at
codons 52, 54, and 57 are deﬁned D, B, and C, respectively. The
wild-type allele is ‘allele A’. The promoter polymorphisms are H/LTable 2
Comparison of haplotype frequencies between healthy controls and rUTI patients
Haplotype Controls F
(n = 616), n (%)
Controls M
(n = 668), n (%)
Case
(n = 
HYPA 235 (39) 253 (38) 28 (3
HYPB 16 (0.9) 17 (2.5) 0 (0
LXPA 104 (17) 120 (18) 10 (1
LXPB 4 (0.6) 4 (0.6) 0 (0
LXQA 30 (5) 28 (4.2) 6 (8
LYPA 127 (21) 137 (20.5) 15 (2
LYPB 8 (1) 8 (1.2) 2 (2
LYQA 87 (14.3) 99 (14.5) 13 (1
LYQB 5 (0.8) 2 (0.3) 0 (0
F, females; M, males.
a p-Values from allele comparison of case F vs. control F.
b p-Values from allele comparison of case M vs. control M.(550), Y/X (221), and P/Q (+4 in the 50 UTR). Seven MBL2
haplotypes were obtained from the combination of the six gene
variants.6,7,10
Hardy–Weinberg equilibrium was evaluated with the good-
ness-of-ﬁt Chi-square test. Differences in the distribution of allele
frequencies between patients and controls were evaluated with a
two-sided Chi-square test. Odds ratios (ORs) and 95% conﬁdence
intervals (CIs) were calculated to assess the relative risk conferred
by a speciﬁc allele. Statistical signiﬁcance was established at p 
0.05.
3. Results
The genotype and haplotype frequencies of single nucleotide
polymorphisms (SNPs) in the MBL2 gene of rUTI patients and
healthy controls stratiﬁed by gender are summarized in Tables 1
and 2. At position 550 of the promoter, the L allele was
signiﬁcantly more frequent in male controls than in patients (p =
0.02). Therefore, we evaluated the MBL2 haplotypes resulting from
the combination of the six gene variants and identiﬁed seven
previously reported haplotypes. Statistical analysis without
correcting for multiple tests revealed that the HYPA (wild-type)
haplotype shows a trend towards an association with a lower risk
of developing rUTI infections in males (Table 2, p = 0.02).s F
74), n (%)
Cases M
(n = 92), n (%)
ap-Value bp-Value
8) 24 (26) 0.87 0.02
) 1 (1.1) 0.32 0.61
3.5) 14 (15.2) 0.43 0.51
) 1 (1.1) 0.92 0.88
) 6 (6.6) 0.25 0.31
0) 25 (27.2) 0.89 0.14
.7) 2 (2.2) 0.67 0.77
7.6) 18 (19.6) 0.46 0.23
) 1 (1.1) 0.95 0.8
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A deﬁciency of the MBL protein is correlated with an increased
susceptibility to various infectious states.5 Mutations in the
promoter region of the MBL gene (i.e., 550C, 221C, and +4T)
cause reduced protein synthesis, while alterations in exon 1 (i.e.,
R52C, G54D, and G57E) give rise to peptides less able to
polymerize, thereby resulting in a lower afﬁnity for the bacterial
surface4 and reduced pro-complementary activity.4,5 Moreover,
altered MBL2 haplotypes decrease the activities of the immuno-
logical protein and increase the occurrence of infections.5
In this study of rUTI patients, we found that the frequencies of
the L allele and of the wild-type HYPA haplotype differed
signiﬁcantly between healthy subjects and rUTI males. To date,
there is no evidence that the L allele in heterozygosis affects
immunological protein activity. Reduced synthesis of MBL occurs
when at least two promoter mutations are present in heterozygo-
sis, which indicates that a single polymorphism probably does not
signiﬁcantly affect the rUTI risk.10 On the other hand, considering
the entire haplotype, we found a signiﬁcantly higher frequency of
the HYPA haplotype in control males than in rUTI males. HYPA is
among the most frequent haplotypes in the normal population and
correlates with high MBL levels. Our data, although preliminary,
suggest that the HYPA MBL2 haplotype may act as a protective
factor against rUTI in males.
In conclusion, this is the ﬁrst study to investigate the correlation
between MBL2 gene variants and rUTI. Our results indicate that
molecular analysis (easily performed by PCR on blood genomic
DNA) could be a diagnostic tool with which to identify subjects
predisposed to rUTI.Acknowledgements
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